401.40
+2.50
+(0.63%)
As of 9:05:15 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 23 | 20 | 29 | 29 |
| Avg. Estimate | 3.47B | 2.81B | 11.26B | 11.68B |
| Low Estimate | 3.4B | 2.78B | 11.18B | 11.57B |
| High Estimate | 3.71B | 2.86B | 11.51B | 11.93B |
| Year Ago Sales | 3.55B | 2.73B | 11.21B | 11.26B |
| Sales Growth (year/est) | -2.30% | 3.21% | 0.50% | 3.72% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ULTA.VI | -- | -- | -- | -- |
| S&P 500 | 9.39% | 11.29% | 14.06% | 13.54% |
Upgrades & Downgrades
| Upgrade | Morgan Stanley: Equal-Weight to Overweight | 1/21/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 1/9/2025 |
| Maintains | TD Cowen: Hold to Hold | 1/8/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 1/7/2025 |
| Maintains | Citigroup: Neutral to Neutral | 1/7/2025 |
| Maintains | B of A Securities: Neutral to Neutral | 1/7/2025 |